1 – 10 of 36
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
- 
                        Mark
        Intermediate Monocytes and High Levels of Chemokine CCL3 Are Associated With Increased Risk of Atrial Fibrillation in the General Population
    
    - Contribution to journal › Article
 
- 
                        Mark
        IFNγ+ NKT-like cells are associated with increased incidence of atrial fibrillation in elderly women
    
    - Contribution to journal › Article
 
- 
                        Mark
        Progenitor exhausted PD-1+ T cells are cellular targets of immune checkpoint inhibition in atherosclerosis
    (2025) In Nature Cardiovascular Research- Contribution to journal › Article
 
- 2024
- 
                        Mark
        Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation
    
    - Contribution to journal › Article
 
- 
                        Mark
        Dysregulation of MMP2-dependent TGF-ß2 activation impairs fibrous cap formation in type 2 diabetes-associated atherosclerosis
    
    - Contribution to journal › Article
 
- 
                        Mark
        Shedding of membrane complement inhibitors CD59 and CD46 into the circulation is associated with poor prognosis in acute coronary syndrome patients : a cohort study
    
    - Contribution to journal › Article
 
- 2023
- 
                        Mark
        Plasma levels of CCL21, but not CCL19, independently predict future coronary events in a prospective population-based cohort
    
    - Contribution to journal › Article
 
- 
                        Mark
        Priorities in Cardio-Oncology Basic and Translational Science : GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review
    
    - Contribution to journal › Scientific review
 
- 
                        Mark
        Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction
    
    - Contribution to journal › Article
 
- 
                        Mark
        Invariant natural killer T cells and incidence of first-time coronary events : a nested case-control study
    
    - Contribution to journal › Article
 
